Tuberculosis Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB509241461

Publication Date:

September 19, 2024

Pages:

109

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

IT Services [2]

Computing & Electronics [3]

Description:

Tuberculosis is a highly infectious bacterial infection, and is caused due to Mycobacterium tuberculosis or MTB infection and majorly infects human lungs. Tuberculosis (TB) can be caught by breathing in air that an infected person has contaminated through: Breathing, coughing. Furthermore, the disease is ranked second leading cause of death, after human immunodeficiency virus (HIV). Individual majorly suffer from two predominant forms of TB: Active tuberculosis and Latent tuberculosis. The global tuberculosis testing market comprises diagnostic tests, equipment鈥檚 and testing procedures that contribute assistance in diagnostic of tuberculosis infection.
The global market for Tuberculosis Testing was estimated to be worth US$ 2466.8 million in 2023 and is forecast to a readjusted size of US$ 2878.6 million by 2030 with a CAGR of 2.2% during the forecast period 2024-2030
North American market for Tuberculosis Testing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Tuberculosis Testing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Tuberculosis Testing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Tuberculosis Testing include Abbott Laboratories, Akonni Biosystems, Abbott, Becton, Dickinson and Company, Cepheid, Epistem Holdings Plc, F. Hoffmann-La Roche AG, Thermo Fischer Scientific and bioM茅rieux SA, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Tuberculosis Testing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Tuberculosis Testing by region & country, by Type, and by Application.
The Tuberculosis Testing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tuberculosis Testing.
Market Segmentation
By Company
Abbott Laboratories
Akonni Biosystems
Abbott
Becton, Dickinson and Company
Cepheid
Epistem Holdings Plc
F. Hoffmann-La Roche AG
Thermo Fischer Scientific
bioM茅rieux SA
Siemens Healthineer
Segment by Type:
Smear Microscopy
Nucleic Acid Testing
Radiography
Culture Based Tests
Drug Susceptibility Testing
Others
Segment by Application
Hospitals
Laboratories
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Tuberculosis Testing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Tuberculosis Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Tuberculosis Testing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Tuberculosis Testing Product Introduction
1.2 Global Tuberculosis Testing Market Size Forecast
1.3 Tuberculosis Testing Market Trends & Drivers
1.3.1 Tuberculosis Testing Industry Trends
1.3.2 Tuberculosis Testing Market Drivers & Opportunity
1.3.3 Tuberculosis Testing Market Challenges
1.3.4 Tuberculosis Testing Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Tuberculosis Testing Players Revenue Ranking (2023)
2.2 Global Tuberculosis Testing Revenue by Company (2019-2024)
2.3 Key Companies Tuberculosis Testing Manufacturing Base Distribution and Headquarters
2.4 Key Companies Tuberculosis Testing Product Offered
2.5 Key Companies Time to Begin Mass Production of Tuberculosis Testing
2.6 Tuberculosis Testing Market Competitive Analysis
2.6.1 Tuberculosis Testing Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Tuberculosis Testing Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis Testing as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Smear Microscopy
3.1.2 Nucleic Acid Testing
3.1.3 Radiography
3.1.4 Culture Based Tests
3.1.5 Drug Susceptibility Testing
3.1.6 Others
3.2 Global Tuberculosis Testing Sales Value by Type
3.2.1 Global Tuberculosis Testing Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Tuberculosis Testing Sales Value, by Type (2019-2030)
3.2.3 Global Tuberculosis Testing Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Laboratories
4.1.3 Others
4.2 Global Tuberculosis Testing Sales Value by Application
4.2.1 Global Tuberculosis Testing Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Tuberculosis Testing Sales Value, by Application (2019-2030)
4.2.3 Global Tuberculosis Testing Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Tuberculosis Testing Sales Value by Region
5.1.1 Global Tuberculosis Testing Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Tuberculosis Testing Sales Value by Region (2019-2024)
5.1.3 Global Tuberculosis Testing Sales Value by Region (2025-2030)
5.1.4 Global Tuberculosis Testing Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Tuberculosis Testing Sales Value, 2019-2030
5.2.2 North America Tuberculosis Testing Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Tuberculosis Testing Sales Value, 2019-2030
5.3.2 Europe Tuberculosis Testing Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Tuberculosis Testing Sales Value, 2019-2030
5.4.2 Asia Pacific Tuberculosis Testing Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Tuberculosis Testing Sales Value, 2019-2030
5.5.2 South America Tuberculosis Testing Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Tuberculosis Testing Sales Value, 2019-2030
5.6.2 Middle East & Africa Tuberculosis Testing Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Tuberculosis Testing Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Tuberculosis Testing Sales Value
6.3 United States
6.3.1 United States Tuberculosis Testing Sales Value, 2019-2030
6.3.2 United States Tuberculosis Testing Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Tuberculosis Testing Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Tuberculosis Testing Sales Value, 2019-2030
6.4.2 Europe Tuberculosis Testing Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Tuberculosis Testing Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Tuberculosis Testing Sales Value, 2019-2030
6.5.2 China Tuberculosis Testing Sales Value by Type (%), 2023 VS 2030
6.5.3 China Tuberculosis Testing Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Tuberculosis Testing Sales Value, 2019-2030
6.6.2 Japan Tuberculosis Testing Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Tuberculosis Testing Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Tuberculosis Testing Sales Value, 2019-2030
6.7.2 South Korea Tuberculosis Testing Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Tuberculosis Testing Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Tuberculosis Testing Sales Value, 2019-2030
6.8.2 Southeast Asia Tuberculosis Testing Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Tuberculosis Testing Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Tuberculosis Testing Sales Value, 2019-2030
6.9.2 India Tuberculosis Testing Sales Value by Type (%), 2023 VS 2030
6.9.3 India Tuberculosis Testing Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Profile
7.1.2 Abbott Laboratories Main Business
7.1.3 Abbott Laboratories Tuberculosis Testing Products, Services and Solutions
7.1.4 Abbott Laboratories Tuberculosis Testing Revenue (US$ Million) & (2019-2024)
7.1.5 Abbott Laboratories Recent Developments
7.2 Akonni Biosystems
7.2.1 Akonni Biosystems Profile
7.2.2 Akonni Biosystems Main Business
7.2.3 Akonni Biosystems Tuberculosis Testing Products, Services and Solutions
7.2.4 Akonni Biosystems Tuberculosis Testing Revenue (US$ Million) & (2019-2024)
7.2.5 Akonni Biosystems Recent Developments
7.3 Abbott
7.3.1 Abbott Profile
7.3.2 Abbott Main Business
7.3.3 Abbott Tuberculosis Testing Products, Services and Solutions
7.3.4 Abbott Tuberculosis Testing Revenue (US$ Million) & (2019-2024)
7.3.5 Becton, Dickinson and Company Recent Developments
7.4 Becton, Dickinson and Company
7.4.1 Becton, Dickinson and Company Profile
7.4.2 Becton, Dickinson and Company Main Business
7.4.3 Becton, Dickinson and Company Tuberculosis Testing Products, Services and Solutions
7.4.4 Becton, Dickinson and Company Tuberculosis Testing Revenue (US$ Million) & (2019-2024)
7.4.5 Becton, Dickinson and Company Recent Developments
7.5 Cepheid
7.5.1 Cepheid Profile
7.5.2 Cepheid Main Business
7.5.3 Cepheid Tuberculosis Testing Products, Services and Solutions
7.5.4 Cepheid Tuberculosis Testing Revenue (US$ Million) & (2019-2024)
7.5.5 Cepheid Recent Developments
7.6 Epistem Holdings Plc
7.6.1 Epistem Holdings Plc Profile
7.6.2 Epistem Holdings Plc Main Business
7.6.3 Epistem Holdings Plc Tuberculosis Testing Products, Services and Solutions
7.6.4 Epistem Holdings Plc Tuberculosis Testing Revenue (US$ Million) & (2019-2024)
7.6.5 Epistem Holdings Plc Recent Developments
7.7 F. Hoffmann-La Roche AG
7.7.1 F. Hoffmann-La Roche AG Profile
7.7.2 F. Hoffmann-La Roche AG Main Business
7.7.3 F. Hoffmann-La Roche AG Tuberculosis Testing Products, Services and Solutions
7.7.4 F. Hoffmann-La Roche AG Tuberculosis Testing Revenue (US$ Million) & (2019-2024)
7.7.5 F. Hoffmann-La Roche AG Recent Developments
7.8 Thermo Fischer Scientific
7.8.1 Thermo Fischer Scientific Profile
7.8.2 Thermo Fischer Scientific Main Business
7.8.3 Thermo Fischer Scientific Tuberculosis Testing Products, Services and Solutions
7.8.4 Thermo Fischer Scientific Tuberculosis Testing Revenue (US$ Million) & (2019-2024)
7.8.5 Thermo Fischer Scientific Recent Developments
7.9 bioM茅rieux SA
7.9.1 bioM茅rieux SA Profile
7.9.2 bioM茅rieux SA Main Business
7.9.3 bioM茅rieux SA Tuberculosis Testing Products, Services and Solutions
7.9.4 bioM茅rieux SA Tuberculosis Testing Revenue (US$ Million) & (2019-2024)
7.9.5 bioM茅rieux SA Recent Developments
7.10 Siemens Healthineer
7.10.1 Siemens Healthineer Profile
7.10.2 Siemens Healthineer Main Business
7.10.3 Siemens Healthineer Tuberculosis Testing Products, Services and Solutions
7.10.4 Siemens Healthineer Tuberculosis Testing Revenue (US$ Million) & (2019-2024)
7.10.5 Siemens Healthineer Recent Developments
8 Industry Chain Analysis
8.1 Tuberculosis Testing Industrial Chain
8.2 Tuberculosis Testing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Tuberculosis Testing Sales Model
8.5.2 Sales Channel
8.5.3 Tuberculosis Testing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Abbott Laboratories
Akonni Biosystems
Abbott
Becton, Dickinson and Company
Cepheid
Epistem Holdings Plc
F. Hoffmann-La Roche AG
Thermo Fischer Scientific
bioM茅rieux SA
Siemens Healthineer

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂